Ulinatryp 100000IU Injection
Marketer
Allites life Sciences Pvt Ltd
Salt Composition
Ulinastatin (100000IU)
Overview Ulinatryp 100000IU Injection
Kallikrein inhibitor injection (100,000 IU) treats severe sepsis and acute pancreatitis by mitigating pancreatic inflammation mediators. Administration is typically by a healthcare professional, with dosage individualized based on patient response and condition. Continued use, as directed by your physician, is crucial; premature cessation may lead to symptom recurrence and disease exacerbation. Inform your doctor of all other medications, as interactions are possible. Common side effects include injection site reactions (pain, swelling, redness) and elevated liver enzymes – typically transient and self-limiting. Report any concerning side effects immediately. This injection is contraindicated in hypersensitivity and breastfeeding. Pregnant or planning pregnancy? Consult your doctor before use. Regular liver function monitoring may be recommended. This medication is not a substitute for standard treatments like blood transfusions, oxygen therapy, or antibiotics in shock management.
Uses of Ulinatryp 100000IU Injection
Acute pancreatitis and severe systemic infection
Major Benefits of Ulinatryp 100000IU Injection:
This medication will be administered by your physician or their associate; self-medication is strictly prohibited.
How to use Ulinatryp 100000IU Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Ulinatryp 100000IU Injection works:
Ulinatryp 100000IU Injection inhibits pancreatic digestive enzymes, thereby mitigating both digestive activity and pancreatic inflammation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ulinatryp 100000IU Injection lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Ulinatryp 100000IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible adverse effects prior to prescribing. Seek medical advice.
Breast feedingCAUTION
Administering Ulinatryp 100000IU Injection to breastfeeding mothers requires careful consideration. Mothers should temporarily discontinue breastfeeding throughout the treatment course and until the medication is fully cleared from their system.
DrivingCONSULT YOUR DOCTOR
The impact of Ulinatryp 100000IU Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with kidney impairment, Ulinatryp 100000IU Injection requires careful administration. Dosage modification of Ulinatryp 100000IU Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Ulinatryp 100000IU Injection appears safe for individuals with hepatic impairment. Available evidence indicates dose modification of Ulinatryp 100000IU Injection may be unnecessary in this population. Physician consultation is recommended.
What if you forget to take Ulinatryp 100000IU Injection :
NA
Facts to Know About Ulinatryp 100000IU Injection
| Label | Value |
|---|---|
| Chemical Type | Short chains of amino acids |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
3,018 People bought this recently